Cargando…

Benefit and harm of lymphadenectomy in intermediate risk prostate cancer: comparison of five nomograms

BACKGROUND: Pelvic lymph node dissection (PLND) is recommended method for detecting prostate cancer (PCa) nodal metastases although associated with serious complications. In this study, we aimed to assess benefit/harm of routine PLND in intermediate risk PCa patients and to compare diagnostic yield...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lodeta, Branimir, Baric, Hrvoje, Hatz, Dominik, Jozipovic, Danijel, Augustin, Herbert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657577/ https://www.ncbi.nlm.nih.gov/pubmed/37980520 http://dx.doi.org/10.1186/s12894-023-01362-y

Ejemplares similares

Prostate Biopsy in the Left Lateral Decubitus Position is Less Painful than Prostate Biopsy in the Lithotomy Position: A Randomized Controlled Trial
por: Lodeta, Branimir, et al.
Publicado: (2012)

Survival benefit of No. 10 lymphadenectomy with spleen preservation
por: Song, Jeong Ho, et al.
Publicado: (2022)

THE ROLE OF LYMPHADENECTOMY IN PROSTATE CANCER PATIENTS
por: Markić, Dean, et al.
Publicado: (2019)

Weighing the benefits of lymphadenectomy in early-stage colorectal cancer
por: Baik, Seung Min, et al.
Publicado: (2023)

Role of lymphadenectomy in intermediate-risk endometrial cancer: a matched-pair study
por: Coronado, Pluvio J., et al.
Publicado: (2018)

Survival benefits of pelvic lymphadenectomy versus pelvic and para-aortic lymphadenectomy in patients with endometrial cancer: A meta-analysis
por: Guo, Weina, et al.
Publicado: (2018)

Chylous Fistula following Axillary Lymphadenectomy: Benefit of Octreotide Treatment
por: González-Sánchez-Migallón, Elena, et al.
Publicado: (2016)

Is there an oncological benefit to extended lymphadenectomy for muscle-invasive bladder cancer?
por: Clinton, Timothy N., et al.
Publicado: (2020)

The Role of Pelvic Lymphadenectomy in the Management of Prostate and Bladder Cancer
por: Woods, Michael E., et al.
Publicado: (2007)

Systematic lymphadenectomy for intermediate risk endometrial carcinoma treatment does not improve the oncological outcome
por: Candido, Elaine C., et al.
Publicado: (2019)

Role of systematic lymphadenectomy in patients with intermediate to high-risk early stage endometrial cancer
por: Kim, Nae Ry, et al.
Publicado: (2022)

Benefits and harms of prostate cancer screening – predictions of the ONCOTYROL prostate cancer outcome and policy model
por: Mühlberger, Nikolai, et al.
Publicado: (2017)

Lifetime Benefits and Harms of Prostate-Specific Antigen–Based Risk-Stratified Screening for Prostate Cancer
por: Heijnsdijk, Eveline A M, et al.
Publicado: (2020)

Utility of Lymphadenectomy in Prostate Cancer: Where Do We Stand?
por: Małkiewicz, Bartosz, et al.
Publicado: (2022)

The Role of Para-Aortic Lymphadenectomy in the Surgical Staging of Women with Intermediate and High-Risk Endometrial Adenocarcinomas
por: May, Taymaa, et al.
Publicado: (2013)

Radiomics Nomogram in Assisting Lymphadenectomy Decisions by Predicting Lymph Node Metastasis in Early-Stage Endometrial Cancer
por: Liu, Xue-Fei, et al.
Publicado: (2022)

Survival Benefit and Safety of No. 10 Lymphadenectomy for Gastric Cancer Patients With Total Gastrectomy
por: Yang, Kun, et al.
Publicado: (2014)

Lymphadenectomy Benefits Small Cell Carcinoma of Ovary: A Population-Based Analysis
por: Wang, Jing, et al.
Publicado: (2022)

Simultaneous Renal Oncocytoma and Lymphoma: Interest of Lymphadenectomy
por: Orcurto, Angela, et al.
Publicado: (2013)

Application value of nomogram and prognostic factors of gastric cancer patients who underwent D2 radical lymphadenectomy
por: Mu, Guang-Chuan, et al.
Publicado: (2019)

Assessment of Sentinel Lymph Node Biopsy vs Lymphadenectomy for Intermediate- and High-Grade Endometrial Cancer Staging
por: Cusimano, Maria C., et al.
Publicado: (2020)

Avoiding Full Lymphadenectomies in Intermediate- and High-Risk Endometrial Cancer by Sentinel Lymph Node Biopsy Implementation
por: Pineda, Virginia García, et al.
Publicado: (2021)

The efficiency of D1(+) lymphadenectomy in signet ring cell carcinoma: comparison of postoperative early and late outcomes between standard lymphadenectomy and D1(+) lymphadenectomy
por: Morkavuk, Şevket Barış, et al.
Publicado: (2021)

Cancer immunotherapy: Benefit and harm?
por: Characiejus, Dainius
Publicado: (2012)

TRIOLOGY ACS: No benefit/No harm
por: Elmahdy, Mahmoud Farouk, et al.
Publicado: (2013)

Benefits and harms of mammography screening
por: Løberg, Magnus, et al.
Publicado: (2015)

A new predictor is comparable to the updated nomogram in predicting the intermediate- and high-risk prostate cancer but outperforms nomogram in reducing the overtreatment for the low-risk Pca
por: Wang, Hui, et al.
Publicado: (2019)

Survival Benefit of Adjuvant Radiation Therapy for Gastric Cancer following Gastrectomy and Extended Lymphadenectomy
por: Snyder, R. A., et al.
Publicado: (2012)

Survival benefit with extended lymphadenectomy for advanced renal malignancy: A population-based analysis
por: Laganosky, Dean, et al.
Publicado: (2020)

Five disciplines for zero patient harm
por: Mowll, Charles
Publicado: (2019)

What is paracervical lymphadenectomy?
por: Querleu, Denis, et al.
Publicado: (2021)

Lymphadenectomy in pulmonary metastasectomy
por: Welter, Stefan, et al.
Publicado: (2021)

Potential benefits of medium chain fatty acids in aging and neurodegenerative disease
por: Dunn, Ella, et al.
Publicado: (2023)

Case report: Incidental metastatic prostate cancer with undetectable PSA in pelvic lymphadenectomy
por: McLeay, Matthew T., et al.
Publicado: (2018)

The survival benefit and safety of No. 12a lymphadenectomy for gastric cancer patients with distal or total gastrectomy
por: Yang, Kun, et al.
Publicado: (2016)

Patient and General Population Preferences Regarding the Benefits and Harms of Treatment for Metastatic Prostate Cancer: A Discrete Choice Experiment
por: Menges, Dominik, et al.
Publicado: (2023)

Indirect Comparison Showed Survival Benefit from Adjuvant Chemoradiotherapy in Completely Resected Gastric Cancer with D2 Lymphadenectomy
por: Yang, Qiong, et al.
Publicado: (2013)

Critical Overview on the Benefits and Harms of Aspirin
por: Kwok, Chun Shing, et al.
Publicado: (2010)

Open Surgery including Lymphadenectomy without Adjuvant Therapy for Uterine-Confined Intermediate- and High-Risk Endometrioid Endometrial Carcinoma
por: Otsuka, Isao, et al.
Publicado: (2022)

Societal changes bring about the imperative to readjust the medical gaze
por: Barić, Hrvoje
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dj1897hipt6u3l9utn57mj2qdh